Synovial Sarcoma Pathology: Diagnostic Features And Genetics

Synovial sarcoma is a rare, aggressive soft tissue malignancy predominantly affecting young adults, characterized by a specific SS18-SSX gene fusion despite not originating from synovial tissue. It typically arises in deep soft tissues near joints, such as the extremities, and requires integrated microscopic, immunohistochemical, and molecular analysis for accurate diagnosis.

Introduction

Synovial sarcoma accounts for 5-10% of all soft tissue sarcomas, with an incidence of approximately 800-1000 cases annually worldwide, primarily in adolescents and adults under 30 years old. Despite its name, it does not arise from synovial lining but from primitive mesenchymal cells, often presenting as a firm, painless mass near tendons or joints. Early detection is crucial due to its propensity for local recurrence and distant metastasis, particularly to lungs.

Clinical Features

Synovial sarcoma commonly manifests in the extremities (80-90% of cases), with the lower limbs (especially near the knee) being the most frequent site. Patients typically present with a slowly enlarging, deep-seated mass, often painless initially but may cause swelling, pain, or limited joint mobility as it grows. Tumors are usually 5-10 cm at diagnosis, though smaller lesions (<5 cm) confer better prognosis. Rare sites include head/neck, trunk, and retroperitoneum. Systemic symptoms are uncommon unless metastatic.

• Demographics: Peak incidence 15-40 years; slight male predominance.
• Symptoms: Painless lump (60%), pain (30%), joint stiffness.
• Imaging: MRI shows heterogeneous mass with calcifications in ~30%.

Histopathology

Microscopically, synovial sarcoma exhibits distinctive biphasic or monophasic patterns with high cellularity, uniform spindle cells, and variable epithelioid/glandular components. Calcifications, hemorrhage, and sclerosis are common stromal features.

Microscopic Appearance

Tumors show densely packed, hyperchromatic spindle cells arranged in fascicles or herringbone patterns, interspersed with collagen bands. Epithelial elements appear as glandular spaces lined by cuboidal cells, often with pink debris. Staghorn-like dilated vascular/glandular spaces mimic solitary fibrous tumor. Necrosis, mitoses, and atypia increase in aggressive variants.

Histological Subtypes

Biphasic synovial sarcoma (classic, 50%): Equal spindle and epithelial components forming true glands.

Monophasic synovial sarcoma (40%): Pure spindle cell proliferation; subtle epithelial foci may be overlooked.

Poorly differentiated synovial sarcoma (10%): High-grade with marked atypia, rhabdoid cells, >6 mitoses/mm², necrosis; worse prognosis.

Cytology

Cytological smears reveal dispersed spindle cells with high N/C ratio, oval nuclei, fine chromatin, and inconspicuous nucleoli. Glandular clusters with vacuolated cytoplasm are seen in biphasic cases. Background may show necrosis or calcifications.

• Spindle cells: Plump, cohesive clusters.
• Epithelial: Acinar formations with lumina.
• High mitotic rate in aggressive tumors.

Histochemical Features

Minimal utility; PAS highlights intracytoplasmic glycogen in epithelial cells. Mucicarmine is negative, distinguishing from mucin-producing tumors. Calcifications stain with von Kossa.

Immunohistochemistry

IHC is pivotal for diagnosis, showing EMA and cytokeratins (AE1/AE3, CAM5.2) positive in epithelial components (strong, diffuse) and focal in spindle cells. TLE1 is highly sensitive/specific (90-100%) nuclear stain.

Negative CD34 and focal S100 aid differential diagnosis.

Genetics

Hallmark is t(X;18)(p11;q11) translocation fusing SS18 (SYT) to SSX1/2/4 (95-100% cases). SS18-SSX1 in biphasic/monophasic fibrous; SS18-SSX2 in monophasic epithelial. Detected by FISH (break-apart probes) or NGS/RT-PCR.

• Frequency: Near-universal.
• Prognostic: SS18-SSX1 worse than SSX2.
• Testing: Recommended for confirmation.

Electron Microscopy

Spindle cells show interdigitating processes, rudimentary junctions, and intermediate filaments. Epithelial cells have microvilli, lumina, and desmosomes, confirming dual differentiation.

Prognosis

5-year survival 50-70%, worse with size >5 cm, high grade, poor differentiation, bone invasion, or non-extremity site. Metastasis risk: lungs (70%), nodes (10-15%).

• Favorable: <5 cm, low grade, extremities.
• Unfavorable: >10 cm, poorly differentiated, truncal.

Differential Diagnosis

Frequently Asked Questions

What is the hallmark genetic abnormality in synovial sarcoma?

The t(X;18) translocation resulting in SS18-SSX fusion, detected in nearly all cases.

How is synovial sarcoma graded?

Using FNCLCC system: differentiation, mitotic count, necrosis. Grade 1-3; high grade >6 mitoses/mm².

What is the role of TLE1 in diagnosis?

TLE1 is a highly sensitive and specific nuclear marker, positive in >90%.

Does synovial sarcoma arise from joint synovium?

No, despite name; from mesenchymal precursors near joints/tendons.

What is the most common metastatic site?

Lungs, in up to 70% of advanced cases.

Treatment Response and Staging

Post-neoadjuvant therapy, assess viable tumor percentage (necrosis >90% = excellent response). TNM staging: pT (size/invasion), N (nodes), M (metastases). N1 if nodal involvement.

Similar Articles

Alarming Rise in Self-Harm in Young People

Alarming Rise in Self-Harm in Young People

Skin Signs Of Non-Accidental Injury: Expert Guide For Clinicians

Lichen Simplex Of The Scrotum: Diagnosis And Treatment

Labial Adhesion In Prepubertal Girls: What Parents Need To Know

Thrush In Men: 5 Signs, Causes, And Treatment Options

Author

Sneha TeteBeauty & Lifestyle Writer

 

Sneha is a relationships and lifestyle writer with a strong foundation in applied linguistics and certified training in relationship coaching. She brings over five years of writing experience to renewcure,  crafting thoughtful, research-driven content that empowers readers to build healthier relationships, boost emotional well-being, and embrace holistic living.

Read full bio of Sneha Tete